Parkinson's Disease Online Powered by the Michael J. Fox Foundation Home
Welcome Guest | Be a part of PD Online Research
  • recover password
FacebookTwitter
  • Discussions
    • LRRK2 Antibodies
    • Protocol Q&A
  • News
    • Papers of the Week
    • Newsletters
  • Resources
    • Genes
    • Research Models
    • Clinical Trials
    • Classifieds
    • PD Guide
  • Funding
    • Funding News
  • Meetings
    • Calendar
    • Meeting Reports
    • Reporter Awards
  • Members
    • Member Directory
    • Apply for Membership

Biblio

  • List
  • Filter
Add Citation
Export 2 results:
  • Endnote
Sort by: Author Title Type [ Year (Desc)]
Filters: Author is Clark, Ira E  [Clear All Filters]
2008
Yun J, Cao JH, Dodson MW, Clark IE, Kapahi P, Chowdhury RB, et al. Loss-of-function analysis suggests that Omi/HtrA2 is not an essential component of the PINK1/PARKIN pathway in vivo. J Neurosci. 2008;28(53):14500-10.
  • Endnote
  • 0
2006
Clark IE, Dodson MW, Jiang C, Cao JH, Huh JR, Seol J, et al. Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature. 2006;441(7097):1162-6.
  • Endnote
  • 0

Latest Discussions

  • LRRK2 Antibodies
    Responses: 37
  • MJFF Closed Next Week
  • Members in the News: Charleen T. Chu Receives Outstanding Investigator Award
    Responses: 1
  • Cognitive Problems May Precede PD Motor Symptoms
    Responses: 1
  • Systems Approaches to Parkinson's Disease
    Responses: 15
more

Latest News

  • MJFF Statement on Halting of Federal Embryonic Stem Cell Funding
    07 Sep 2010
    MJFF has released an official statement on the recent injunction halting the use of federal funds to support embryonic stem cell research. ... 
  • ReMYND Scores $637M Deal with Roche
    07 Sep 2010
    ReMynd, a Belgian biotech company, announced today that it has received follow-on funding from pharma giant Roche for a potentially disease-modifying Parkinson's drug whose development MJFF ... 
  • MJFF Closed Next Week
    27 Aug 2010
    MJFF is closed next week, but news will be back up after Labor Day! ... 
  • Gila Monster Venom Trial to Treat PD Underway in U.K.
    27 Aug 2010
    Researchers at University College London Hospitals (U.K.) are starting a clinical trial to test Exenatide, a synthetic version of a compound originally found in Gila monster saliva. MJFF has funded ... 
more

Upcoming Events

  • Autophagy: From Molecules to Disease
    08 Sep 2010 - 12 Sep 2010
  • 2010 World Molecular Imaging Congress
    08 Sep 2010 - 11 Sep 2010
  • Stem Cells USA and Regenerative Medicine Congress 2010
    13 Sep 2010 - 15 Sep 2010
more

Funding Opportunities

  • RFP: Novel Biomarkers to Accelerate Drug Discovery for Frontotemporal Dementias
    The Association for Frontotemporal Dementias
    09 Sep 2010
  • 2011 NIH Director’s Pioneer Award Program (DP1)
    National Institutes of Health (NIH)
    13 Sep 2010
  • Clinical and Basic Research: Parkinson's Disease and Dystonia
    The Bachmann-Strauss Dystonia & Parkinson Foundation
    13 Sep 2010
  • Dekker RFP: Clinical Aspects of Parkinson's Disease
    The Bachmann-Strauss Dystonia & Parkinson Foundation
    13 Sep 2010
  • Dystonia RFP
    The Bachmann-Strauss Dystonia & Parkinson Foundation
    13 Sep 2010
more
  • About
  • Terms
  • who we are
  • The Michael J. Fox Foundation
  • Posting Tips
  • how to cite us
  • contact us
FacebookTwitter